Colinz Laboratories - Quaterly Results

31 Jan 2024 Evaluate
The total revenue for the quarter ended December 2023 remained nearly unchanged at Rs. 17.14 millions.Net profit showed a marginal rise at Rs. 1.05 millions for the quarter ended December 2023, as compared to corresponding quarter of last year.Operating Profit saw a handsome growth to 1.88 millions from 1.80 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 17.14 16.80 2.02 53.99 54.35 -0.66 71.55 69.74 2.60
Other Income 0.48 0.43 11.63 1.68 1.29 30.23 1.72 1.71 0.58
PBIDT 1.88 1.80 4.44 5.85 5.79 1.04 7.80 7.57 3.04
Interest 0.10 0.14 -28.57 0.27 0.39 -30.77 0.52 0.76 -31.58
PBDT 1.78 1.66 7.23 5.58 5.40 3.33 7.28 6.81 6.90
Depreciation 0.33 0.32 3.13 0.99 0.96 3.13 1.29 2.01 -35.82
PBT 1.45 1.34 8.21 4.59 4.44 3.38 5.99 4.80 24.79
TAX 0.40 0.30 33.33 1.11 1.13 -1.77 1.43 1.41 1.42
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.16 -0.09 77.78
PAT 1.05 1.04 0.96 3.48 3.31 5.14 4.56 3.39 34.51
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 35.45 -28.94
PBIDTM(%) 10.97 10.71 2.37 10.84 10.65 1.71 10.90 10.85 0.43

Colinz Laboratories Share Price

71.71 1.24 (1.76%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.